These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29671582)

  • 1. DARK Side of Amphetamine and Analogues: Pharmacology, Syndromic Manifestation, and Management of Amphetamine Addiction.
    Baig AM
    ACS Chem Neurosci; 2018 Oct; 9(10):2299-2303. PubMed ID: 29671582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychophysiological aspects of amphetamine-methamphetamine abuse.
    Murray JB
    J Psychol; 1998 Mar; 132(2):227-37. PubMed ID: 9529666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic landscape of amphetamine and methamphetamine addiction in rodents.
    Godino A; Jayanthi S; Cadet JL
    Epigenetics; 2015; 10(7):574-80. PubMed ID: 26023847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of methamphetamine within the catecholamine and serotonin areas of the central nervous system.
    Chiu VM; Schenk JO
    Curr Drug Abuse Rev; 2012 Sep; 5(3):227-42. PubMed ID: 22998621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor gamma activation relieves expression of behavioral sensitization to methamphetamine in mice.
    Maeda T; Kiguchi N; Fukazawa Y; Yamamoto A; Ozaki M; Kishioka S
    Neuropsychopharmacology; 2007 May; 32(5):1133-40. PubMed ID: 17019405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment related to blood amphetamine and/or methamphetamine concentrations in suspected drugged drivers.
    Gustavsen I; Mørland J; Bramness JG
    Accid Anal Prev; 2006 May; 38(3):490-5. PubMed ID: 16343411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental perspectives on methamphetamine abuse: Exploring adolescent vulnerabilities on brain and behavior.
    Luikinga SJ; Kim JH; Perry CJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Dec; 87(Pt A):78-84. PubMed ID: 29128447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Roche Abuscreen ONLINE amphetamine immunoassay for screening of new amphetamine analogues.
    Lekskulchai V; Mokkhavesa C
    J Anal Toxicol; 2001 Sep; 25(6):471-5. PubMed ID: 11550823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychiatric Adverse Effects of Amphetamine and Methamphetamine.
    Harro J
    Int Rev Neurobiol; 2015; 120():179-204. PubMed ID: 26070758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acute effects of methamphetamine, amphetamine and p-chloroamphetamine on the cortical serotonergic system of the rat brain: evidence for differences in the effects of methamphetamine and amphetamine.
    Peat MA; Warren PF; Bakhit C; Gibb JW
    Eur J Pharmacol; 1985 Oct; 116(1-2):11-6. PubMed ID: 2414113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in regional brain metabolism associated with marijuana abuse in methamphetamine abusers.
    Voytek B; Berman SM; Hassid BD; Simon SL; Mandelkern MA; Brody AL; Monterosso J; Ling W; London ED
    Synapse; 2005 Aug; 57(2):113-5. PubMed ID: 15906384
    [No Abstract]   [Full Text] [Related]  

  • 12. Tolerance of rats toward amphetamine and methamphetamine.
    HARRISSON JW; AMBRUS CM; AMBRUS JL
    J Am Pharm Assoc Am Pharm Assoc; 1952 Oct; 41(10):539-41. PubMed ID: 12999608
    [No Abstract]   [Full Text] [Related]  

  • 13. DARK Classics in Chemical Neuroscience: Methamphetamine.
    Abbruscato TJ; Trippier PC
    ACS Chem Neurosci; 2018 Oct; 9(10):2373-2378. PubMed ID: 29602278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPed-up adolescents: The role of age in the abuse of amphetamines and its consequences on cognition and prefrontal cortex development.
    Westbrook SR; Carrica LK; Banks A; Gulley JM
    Pharmacol Biochem Behav; 2020 Nov; 198():173016. PubMed ID: 32828971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphetamine-Type Stimulants: The Early History of Their Medical and Non-Medical Uses.
    Rasmussen N
    Int Rev Neurobiol; 2015; 120():9-25. PubMed ID: 26070751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. REACTIONS TO USE OF AMPHETAMINES AS OBSERVED IN A PSYCHIATRIC HOSPITAL.
    PROUT CT
    N Y State J Med; 1964 May; 64():1186-92. PubMed ID: 14144137
    [No Abstract]   [Full Text] [Related]  

  • 17. Human methamphetamine pharmacokinetics simulated in the rat: single daily intravenous administration reveals elements of sensitization and tolerance.
    Segal DS; Kuczenski R
    Neuropsychopharmacology; 2006 May; 31(5):941-55. PubMed ID: 16123749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucocutaneous alterations and complications in amphetamine abusers: a narrative review.
    Balali-Mood M; Sinclair RD; Darchini-Maragheh E; Etemad L
    Cutan Ocul Toxicol; 2023 Dec; 42(4):219-231. PubMed ID: 37450708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature.
    Courtney KE; Ray LA
    Drug Alcohol Depend; 2014 Oct; 143():11-21. PubMed ID: 25176528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurologic manifestations of chronic methamphetamine abuse.
    Rusyniak DE
    Psychiatr Clin North Am; 2013 Jun; 36(2):261-75. PubMed ID: 23688691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.